Syndecan-4 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemSyndecan-4 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-36588
Gene Namesyndecan 4
Quantity10 µM
Specieshuman
NCBI Full Gene Namesyndecan 4
NCBI Gene AliasesSYND4
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Exploring the Syndecan-Mediated Cellular Internalization of the SARS-CoV-2 Omicron VariantInternational journal of molecular sciencesSeptember 15, 2023Letoha A, Hudák A, Letoha T.previously, using a lentiviral vector system specific to human SDC4 shRNA (cat. nos. sc-41400-SH an sc-36588), according to the manufacturer’s protocol (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) [37]. Stable

(2) Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9International journal of molecular sciencesFebruary 5, 2023Hudák A, Roach M, Pusztai D, Pettkó-Szandtner A, Letoha A, Szilák L, Azzouz M, Letoha T.

(3) Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior TransmissionInternational journal of molecular sciencesJanuary 12, 2022Hudák A, Veres G, Letoha A, Szilák L, Letoha T.was performed using a lentiviral vector system specific to human SDC4 shRNA (cat. no. sc-41400-SH, sc-36588), according to the manufacturer’s protocol (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Stable

(4) Contribution of Syndecans to the Cellular Entry of SARS-CoV-2International journal of molecular sciencesMay 19, 2021Hudák A, Letoha A, Szilák L, Letoha T.performed using a lentiviral vector system specific to human ACE2 and SDC4 shRNA (cat. nos. sc-41400-SH, sc-36588) according to the manufacturer’s protocol (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Stable

(5) Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental ColitisInflammatory bowel diseasesNovember 29, 2018Fröhling M, Tepasse P, Intemann J, Sambale M, Sherwood J, Paruzel P, Tiemeyer NM, Nowacki TM, Brückner M, Mennigen R, et al.

(6) Killing two birds with one stone: dual blockade of integrin and FGF signaling through targeting syndecan-4 in postoperative capsular opacificationCell death & diseaseJuly 13, 2017Qin Y, Zhu Y, Luo F, Chen C, Chen X, Wu M.six-well culture plate until they reached 70% confluence and were then transfected with SDC-4 siRNA (sc-36588, Santa Cruz Biotechnology, CA, USA) or scrambled siRNA (sc-37007, Santa Cruz Biotechnology) according

(7) Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healingThe journal of histochemistry and cytochemistry : official journal of the Histochemistry SocietyApril 1, 2015Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO.protocol provided by the manufacturer. Briefly, cells were reversely transfected with syndecan-4 siRNA (sc-36588; Santa Cruz Biotechnology, Dallas, TX) for 5 h followed by a 5 h forward transfection with a 16 h interval between

(8) The role of caveolin-1 and syndecan-4 in the internalization of PEGylated PAMAM dendrimer polyplexes into myoblast and hepatic cellsEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.VNovember 1, 2014Shen W, van Dongen MA, Han Y, Yu M, Li Y, Liu G, Banaszak Holl MM, Qi R.

(9) Dynamic catch of a Thy-1-α5β1+syndecan-4 trimolecular complexNature communicationsSeptember 12, 2014Fiore VF, Ju L, Chen Y, Zhu C, Barker TH.Cruz, CA) were used at concentrations of 20 mg ml 1. For Syn4 siRNA knockdown, human Syn4 siRNA (SC-36588; Santa Cruz Biotechnology) or scrambled control siRNA (SC-37007; Santa Cruz Biotechnology) was transfected

(10) Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier functionCellOctober 12, 2012Jin J, Sison K, Li C, Tian R, Wnuk M, Sung HK, Jeansson M, Zhang C, Tucholska M, Jones N, et al.

(11) Switch in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motilityExperimental dermatologyJuly 1, 2007Averbeck M, Gebhardt C, Anderegg U, Termeer C, Sleeman JP, Simon JC.

Be the First to Write a Review!